UofG scientists receive £3M award for pioneering Scottish leukaemia trial

Issued: Fri, 14 Sep 2018 11:25:00 BST

Researchers at the University of Glasgow’s Institute of Cancer Sciences have been awarded £3.1M by Cancer Research UK to lead a pioneering study to help find new treatments for chronic myeloid leukaemia (CML).

Professor Mhairi Copland, Director of the Paul O’Gorman Leukaemia Research Centre, and Dr David Vetrie, Senior Lecturer in Epigenetics, who are leading the study, hope that data from their experiments will help guide which drug will be most effective for individual patients.

Dr Vetrie commented: “We will take and analyse thousands of individual CML stem cells from patients enrolled in our clinical trial, and study the biology of these cells both before and after treatment with new drugs”.